Hemophilia

  • NovoSeven RT 2016 report

    NovoSeven RT 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this...

  • Obizur 2016 report

    Obizur 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Xyntha Solofuse 2016 report

    Xyntha Solofuse 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this...

  • Advate 2015 report

    Advate 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 26 Pages The 5 Key Questions Addressed by this...

  • Alprolix 2015 report

    Alprolix 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 23 Pages The 5 Key Questions Addressed by this...

  • Eloctate 2015 report

    Eloctate 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Kogenate 2015 report

    Kogenate 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Novoeight 2015 report

    Novoeight 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • NovoSeven RT 2015 report

    NovoSeven RT 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by...

  • Xyntha Solofuse 2015 report

    Xyntha Solofuse 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by...

  • Advate 2014 report

    Advate 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 23 Pages The 5 Key Questions Addressed by this...

  • Alprolix 2014 report

    Alprolix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...